ArticleMolecular genetics & genomic medicine2026
Novel LAMA1 Mutations in a Pedigree With Poretti-Boltshauser Syndrome: Implications for Hypomyelination.
Article in Molecular genetics & genomic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundPoretti-Boltshauser syndrome (PBS) is an autosomal recessive disorder caused by biallelic pathogenic variants in the LAMA1 gene, typically presenting with cerebellar dysplasia and fourth ventricle abnormalities. While neurological and ocular manifestations are well recognized, an association between LAMA1 variants and central nervous system (CNS) dysmyelination has not been previously established, and the underlying mechanisms remain unexplored. CASE PRESENTATION: We report two pediatric siblings from a single family with novel compound heterozygous LAMA1 variants [c.505C>T (p.Arg169Ter) and c.634del (p.Ser212HisfsTer28)]. Both patients presented with classic PBS features including ataxia, developmental delay, and oculomotor apraxia. Neuroimaging confirmed cerebellar dysplasia and fourth ventricle abnormalities. Notably, we observed the unexpected concurrence of cerebral white matter hypomyelination, a finding rarely associated with PBS.
conclusionsThis report presents the first clinical evidence linking novel LAMA1 variants to cerebral hypomyelination in PBS, based on the concordant observation in two affected siblings from the same family. Its specific association with LAMA1-related PBS had not been clearly delineated previously. Drawing on insights from the literature, we hypothesize that LAMA1 dysfunction may disrupt key stages of oligodendrocyte precursor cell biology, specifically survival, proliferation, migration, and differentiation, providing a potential mechanistic basis for the CNS hypomyelination observed in our patients. These findings expand both the phenotypic and genotypic spectrum associated with LAMA1 mutations and offer new insights into possible mechanisms of CNS hypomyelination in PBS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.